| 发明名称 |
CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-HEPTANOIC ACID CALCIUM SALT (2:1) |
| 摘要 |
Novel crystalline forms of atorvastatin calcium designated Fa and Je which a re prepared by crystallization from non-aqueous, non-polar solvents at a temperature above 90~C. The crystalline forms are useful as agents for treating hyperlipidemia and hypercholesterolemia.
|
| 申请公布号 |
CA2470114(A1) |
申请公布日期 |
2003.06.19 |
| 申请号 |
CA20022470114 |
申请日期 |
2002.12.11 |
| 申请人 |
IVAX PHARMACEUTICALS S.R.O. |
发明人 |
FAUSTMANN, JIRI;JEGOROV, ALEXANDR |
| 分类号 |
A61K31/40;A61K31/401;A61P3/06;A61P43/00;C07D207/32;C07D207/337;C07D207/34;(IPC1-7):C07D207/327 |
主分类号 |
A61K31/40 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
